Should Oculis Completing Phase 3 Trials for Topical DME Drug OCS-01 Require Action From OCS Investors?

Oculis Holding AG recently completed the final patient visits in its two Phase 3 DIAMOND trials of OCS-01, a topical dexamethasone eye drop being studied over 52 weeks as a potential first ...
Healio

OCS-05 meets safety, efficacy endpoints in acute optic neuritis trial

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The phase 2 ACUITY trial evaluated OCS-05 at 2 mg/kg/day ...
Healio

OCS-01 eye drops meet primary, secondary endpoints in diabetic macular edema phase 3 trial

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. OCS-01 showed a statistically significant improvement in ...
usace.army.mil

Joint exercise implements OCS planning and readiness tenets

JOINT BASE SAN ANTONIO-FORT SAM HOUSTON, Texas -- (Feb. 26, 2016) "We're simply not going to go to war without contractors," said Ashton Carter, then-undersecretary of Defense for acquisition, ...